HomeInsightsStock Comparison

Indoco Remedies Ltd vs Sanofi India Ltd Stock Comparison

Indoco Remedies Ltd vs Sanofi India Ltd Stock Comparison

Last Updated on: May 01, 2025

Key Highlights

  • The Latest Trading Price of Indoco Remedies Ltd is ₹ 232.5 as of 30 Apr 15:30.
  • The p/e ratio of Indoco Remedies Ltd changed from 79.9 to 30.8 over 5 quarters. This represents a CAGR of -53.36% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% .
  • The market cap of Indoco Remedies Ltd changed from ₹ 1929 crore to ₹ 3027 crore over 5 quarters. This represents a CAGR of 43.39% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% .
  • The revenue of Indoco Remedies Ltd for the Dec '24 is ₹ 412.39 crore as compare to the Sep '24 revenue of ₹ 434.22 crore. This represent the decline of -5.03% The revenue of Sanofi India Ltd for the Dec '24 is ₹ 526.3 crore as compare to the Sep '24 revenue of ₹ 503.3 crore. This represent the growth of 4.57%.
  • The ebitda of Indoco Remedies Ltd for the Dec '24 is ₹ 13.87 crore as compare to the Sep '24 ebitda of ₹ 41.81 crore. This represent the decline of -66.83% The ebitda of Sanofi India Ltd for the Dec '24 is ₹ 122 crore as compare to the Sep '24 ebitda of ₹ 136.5 crore. This represent the decline of -10.62%.
  • The net profit of Indoco Remedies Ltd changed from ₹ 24.18 crore to ₹ -28.4 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Sanofi India Ltd changed from ₹ 190.4 crore to ₹ 82.2 crore over 7 quarters. This represents a CAGR of -38.12% .
  • The dividend payout of Indoco Remedies Ltd changed from 11.4 % to 11.86 % over 5 quarters. This represents a CAGR of 3.22% The dividend payout of Sanofi India Ltd changed from 175.77 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

About Sanofi India Ltd

  • Sanofi India Limited, (Previously known as Aventis Pharma Limited) was incorporated in May, 1956.
  • The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
  • The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
  • The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
  • It has its own manufacturing facility at Goa.

Indoco Remedies Ltd News Hub

News

Indoco Remedies Ltd leads losers in 'B' group

Premier Energies Ltd, Shiva Texyarn Ltd, Waaree Energies Ltd and Khandwala Securities Ltd ...

Read more

22 Jan 2025 14:45

News

Indoco Remedies slides on recording dismal Q3 numbers in FY25

Revenue from operations stood at Rs 364.91 crore in the third quarter of FY25, down 18.61%...

Read more

21 Jan 2025 12:53

News

Indoco Remedies allots 65,700 equity shares under ESOP

Indoco Remedies has allotted 65,700 equity shares under ESOP on 21 January 2025. With this...

Read more

21 Jan 2025 13:25

News

Indoco Remedies announces board meeting date

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 21 January...

Read more

13 Jan 2025 17:30

News

Indoco Remedies drops as Goa unit gets OAI status from USFDA

Subsequently, the Goa facility has received a warning letter from the United States Food a...

Read more

17 Dec 2024 12:00

News

Indoco Remedies gains on inking pact with Clarity Pharma

Under this collaboration, Indoco will launch around 20 products in the UK over the next 18...

Read more

03 Dec 2024 10:37

Sanofi India Ltd News Hub

News

Sanofi India MD Rodolfo Hrosz resigns

The board of directors accepted Hrosz's resignation during a meeting held on 9 April and e...

Read more

11 Apr 2025 11:01

News

Sanofi India to convene AGM

Sanofi India announced that the 69th Annual General Meeting(AGM) of the company will be he...

Read more

19 Mar 2025 12:01

News

Board of Sanofi India recommends final dividend

Sanofi India announced that the Board of Directors of the Company at its meeting held on 2...

Read more

28 Feb 2025 09:13

News

Board of Schaeffler India recommends Final Dividend

Schaeffler India announced that the Board of Directors of the Company at its meeting held ...

Read more

27 Feb 2025 17:28

News

Sanofi India to conduct board meeting

Sanofi India will hold a meeting of the Board of Directors of the Company on 27 February 2...

Read more

14 Feb 2025 09:41

News

Sanofi India to discuss results

Sanofi India will hold a meeting of the Board of Directors of the Company on 7 November 20...

Read more

18 Oct 2024 10:45

SWOT Analysis Of Sanofi India Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Indoco Remedies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Sanofi India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Indoco Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Indoco Remedies Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Indoco Remedies Ltd or Sanofi India Ltd?

Market cap of Indoco Remedies Ltd is 2,144 Cr while Market cap of Sanofi India Ltd is 13,662 Cr

What are the key factors driving the stock performance of Indoco Remedies Ltd and Sanofi India Ltd?

The stock performance of Indoco Remedies Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indoco Remedies Ltd and Sanofi India Ltd?

As of May 1, 2025, the Indoco Remedies Ltd stock price is INR ₹232.5. On the other hand, Sanofi India Ltd stock price is INR ₹5932.35.

How do dividend payouts of Indoco Remedies Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Indoco Remedies Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions